Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DMRA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
DMRA
Damora Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
DMRA
Damora Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
DMRA
with
LLY
No shared trading history for DMRA and LLY.
Shared co-movers: not yet measured (DMRA).
DMRA, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
DMRA
Damora Therapeutics, Inc.
Change
22.84
▲
+3.45%
· post 22.84
Mkt cap
$1.4B
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Closed
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 4 '26
DMRA
Damora Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
22.84
▲
+3.45%
post 22.84
Price
1,417.89
▲
+0.60%
post 1,419.27
$1.4B
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
DMRA
22.84
▲
+3.45%
vs
LLY
1,417.89
▲
+0.60%
Closed
Nov 4 '26